Torthaí cuardaigh - Jonas Jögi

  • 1 - 18 toradh as 18 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Ventilation–Perfusion SPECT with <sup>99m</sup>Tc-DTPA Versus Technegas: A Head-to-Head Study in Obstructive and Nonobstructive Disease

    Ventilation–Perfusion SPECT with <sup>99m</sup>Tc-DTPA Versus Technegas: A Head-to-Head Study in Obstructive and Nonobstructive Disease de réir Jonas Jögi, B. Jonson, Marie Ekberg, Marika Bajc

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT

    Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT de réir Jonas Jögi, Marie Ekberg, B. Jonson, Gracijela Božović, Marika Bajc

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

    Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948 de réir Ruben Smith, Michael Schöll, Antoine Leuzy, Jonas Jögi, Tomas Ohlsson, Olof Strandberg, Oskar Hansson

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease

    Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease de réir Michael Schöll, Rik Ossenkoppele, Olof Strandberg, Sebastian Palmqvist, Jonas Jögi, Tomas Ohlsson, Ruben Smith, Oskar Hansson

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms

    Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms de réir Ruben Smith, Douglas Hägerström, Daria Pawlik, Gregory Klein, Jonas Jögi, Tomas Ohlsson, Erik Stomrud, Oskar Hansson

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks

    Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks de réir Oskar Hansson, Michel J. Grothe, Tor Olof Strandberg, Tomas Ohlsson, Douglas Hägerström, Jonas Jögi, Ruben Smith, Michael Schöll

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study

    Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study de réir Niklas Mattsson, Rik Ossenkoppele, Ruben Smith, Olof Strandberg, Tomas Ohlsson, Jonas Jögi, Sebastian Palmqvist, Erik Stomrud, Oskar Hansson

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    In vivo retention of <sup>18</sup> F-AV-1451 in corticobasal syndrome

    In vivo retention of <sup>18</sup> F-AV-1451 in corticobasal syndrome de réir Ruben Smith, Michael Schöll, Håkan Widner, Danielle van Westen, Per Svenningsson, Douglas Hägerström, Tomas Ohlsson, Jonas Jögi, Christer Nilsson, Oskar Hansson

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    <scp>I</scp>ncreased basal ganglia binding of <sup>18</sup><scp>F‐AV‐1451</scp> in patients with progressive supranuclear palsy

    <scp>I</scp>ncreased basal ganglia binding of <sup>18</sup><scp>F‐AV‐1451</scp> in patients with progressive supranuclear palsy de réir Ruben Smith, Martin Schain, Christer Nilsson, Olof Strandberg, Tomas Olsson, Douglas Hägerström, Jonas Jögi, Edilio Borroni, Michael Schöll, Michael Honer, Oskar Hansson

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    <sup>18</sup>F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

    <sup>18</sup>F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease de réir Niklas Mattsson, Michael Schöll, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Jonas Jögi, Kaj Blennow, Oskar Hansson

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Comparing <sup>18</sup> F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

    Comparing <sup>18</sup> F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease de réir Niklas Mattsson, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Michael Schöll, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Kaj Blennow, Jonas Jögi, Oskar Hansson

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Modeling Strategies for Quantification of In Vivo <sup>18</sup>F-AV-1451 Binding in Patients with Tau Pathology

    Modeling Strategies for Quantification of In Vivo <sup>18</sup>F-AV-1451 Binding in Patients with Tau Pathology de réir Andreas Hahn, Martin Schain, Maria Erlandsson, Petter Sjölin, Gregory M. James, Olof Strandberg, Douglas Hägerström, Rupert Lanzenberger, Jonas Jögi, Tomas G. Olsson, Ruben Smith, Oskar Hansson

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders

    Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders de réir Antoine Leuzy, Ruben Smith, Rik Ossenkoppele, Alexander Santillo, Edilio Borroni, Gregory Klein, Tomas Ohlsson, Jonas Jögi, Sebastian Palmqvist, Niklas Mattsson, Olof Strandberg, Erik Stomrud, Oskar Hansson

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Discriminative Accuracy of [<sup>18</sup>F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders

    Discriminative Accuracy of [<sup>18</sup>F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders de réir Rik Ossenkoppele, Gil D. Rabinovici, Ruben Smith, Hanna Cho, Michael Schöll, Olof Strandberg, Sebastian Palmqvist, Niklas Mattsson, Shorena Janelidze, Alexander Santillo, Tomas Ohlsson, Jonas Jögi, Richard Tsai, Renaud La Joie, Joel H. Kramer, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Bruce L. Miller, Jae Yong Choi, Young Hoon Ryu, Chul Hyoung Lyoo, Oskar Hansson

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases

    The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases de réir Ruben Smith, Francesca Capotosti, Martin Schain, Tomas Ohlsson, Efthymia Vokali, Jérôme Molette, Tanja Touilloux, Valerie Hliva, Ioannis K. Dimitrakopoulos, Andreas Puschmann, Jonas Jögi, Per Svenningsson, Mattias Andréasson, Christine M. Sandiego, David Russell, Patricia Miranda‐Azpiazu, Christer Halldin, Erik Stomrud, Sara Hall, Klas Bratteby, Elina Tampio L’Estrade, Ruth Luthi‐Carter, Andrea Pfeifer, Marie Kosco‐Vilbois, Johannes Streffer, Oskar Hansson

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

    Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline de réir Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Erik Stomrud, Pontus Tideman, Tomas Ohlsson, Jonas Jögi, Keith A. Johnson, Reisa A. Sperling, Vincent Doré, Colin L. Masters, Christopher C. Rowe, Denise Visser, Bart N. M. van Berckel, Wiesje M. van der Flier, Suzanne L. Baker, William J. Jagust, Heather J. Wiste, Ronald C. Petersen, Clifford R. Jack, Oskar Hansson

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    The impact of demographic, clinical, genetic, and imaging variables on tau PET status

    The impact of demographic, clinical, genetic, and imaging variables on tau PET status de réir Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, Carole H. Sudre, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, Tomas Olsson, Jonas Jögi, Erik Stormrud, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Bruce L. Miller, David N. Soleimani‐Meigooni, Leonardo Iaccarino, Renaud La Joie, Edilio Borroni, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, Sylvia Villeneuve, Chul Hyoung Lyoo, Gil D. Rabinovici, Oskar Hansson

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease

    Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease de réir Rik Ossenkoppele, Ruben Smith, Niklas Mattsson, Colin Groot, Antoine Leuzy, Olof Strandberg, Sebastian Palmqvist, Tomas Olsson, Jonas Jögi, Erik Stormrud, Hanna Cho, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Bruce L. Miller, David N. Soleimani‐Meigooni, Leonardo Iaccarino, Renaud La Joie, Suzanne L. Baker, Edilio Borroni, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, William J. Jagust, Chul Hyoung Lyoo, Gil D. Rabinovici, Oskar Hansson

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: